We discovered that hypersialylation on tumor cells and the extracellular tumor matrix results in an immunesuppressive tumor microenvironment through engagement of sialic acid-binding Siglec receptors on immune cells including CD8 T cells. The gene discussed is CD8A; the disease is neoplasm.